BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16857740)

  • 1. S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells.
    Zaman K; Carraro S; Doherty J; Henderson EM; Lendermon E; Liu L; Verghese G; Zigler M; Ross M; Park E; Palmer LA; Doctor A; Stamler JS; Gaston B
    Mol Pharmacol; 2006 Oct; 70(4):1435-42. PubMed ID: 16857740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it go or NO go for S-nitrosylation modification-based therapies of cystic fibrosis transmembrane regulator trafficking?
    Zeitlin PL
    Mol Pharmacol; 2006 Oct; 70(4):1155-8. PubMed ID: 16877677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation.
    Zaman K; McPherson M; Vaughan J; Hunt J; Mendes F; Gaston B; Palmer LA
    Biochem Biophys Res Commun; 2001 Jun; 284(1):65-70. PubMed ID: 11374871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70.
    Farinha CM; Nogueira P; Mendes F; Penque D; Amaral MD
    Biochem J; 2002 Sep; 366(Pt 3):797-806. PubMed ID: 12069690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy.
    Marozkina NV; Yemen S; Borowitz M; Liu L; Plapp M; Sun F; Islam R; Erdmann-Gilmore P; Townsend RR; Lichti CF; Mantri S; Clapp PW; Randell SH; Gaston B; Zaman K
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11393-8. PubMed ID: 20534503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of S-nitrosoglutathione and L-cysteine on chloride efflux from cystic fibrosis airway epithelial cells.
    Servetnyk Z; Jiang S; Hjelte L; Gaston B; Roomans GM; Dragomir A
    Exp Mol Pathol; 2011 Feb; 90(1):79-83. PubMed ID: 20965165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel s-nitrosothiols have potential therapeutic uses for cystic fibrosis.
    Zaman K; Fraser-Butler M; Bennett D
    Curr Pharm Des; 2013; 19(19):3509-20. PubMed ID: 23331028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
    Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
    Namkung W; Kim KH; Lee MG
    Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traffic-independent function of the Sar1p/COPII machinery in proteasomal sorting of the cystic fibrosis transmembrane conductance regulator.
    Fu L; Sztul E
    J Cell Biol; 2003 Jan; 160(2):157-63. PubMed ID: 12538638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1.
    Zaman K; Palmer LA; Doctor A; Hunt JF; Gaston B
    Biochem J; 2004 May; 380(Pt 1):67-74. PubMed ID: 14766015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network.
    Lipecka J; Norez C; Bensalem N; Baudouin-Legros M; Planelles G; Becq F; Edelman A; Davezac N
    J Pharmacol Exp Ther; 2006 May; 317(2):500-5. PubMed ID: 16424149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dissection of the butyrate action revealed the involvement of mitogen-activated protein kinase in cystic fibrosis transmembrane conductance regulator biogenesis.
    Sugita M; Kongo H; Shiba Y
    Mol Pharmacol; 2004 Nov; 66(5):1248-59. PubMed ID: 15304546
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zaman K; Knight J; Hussain F; Cao R; Estabrooks SK; Altawallbeh G; Holloway K; Jafri A; Sawczak V; Li Y; Getsy P; Sun F; Raffay T; Cotton C; Brodsky JL; Periasamy A; Lewis SJ; Gaston B
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):765-775. PubMed ID: 31596601
    [No Abstract]   [Full Text] [Related]  

  • 15. S-Nitrosothiols increases cystic fibrosis transmembrane regulator expression and maturation in the cell surface.
    Zaman K; Bennett D; Fraser-Butler M; Greenberg Z; Getsy P; Sattar A; Smith L; Corey D; Sun F; Hunt J; Lewis SJ; Gaston B
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1257-62. PubMed ID: 24393850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of CFTR maturation by S-nitrosoglutathione reductase.
    Zaman K; Sawczak V; Zaidi A; Butler M; Bennett D; Getsy P; Zeinomar M; Greenberg Z; Forbes M; Rehman S; Jyothikumar V; DeRonde K; Sattar A; Smith L; Corey D; Straub A; Sun F; Palmer L; Periasamy A; Randell S; Kelley TJ; Lewis SJ; Gaston B
    Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(3):L263-70. PubMed ID: 26637637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin.
    Harada K; Okiyoneda T; Hashimoto Y; Oyokawa K; Nakamura K; Suico MA; Shuto T; Kai H
    Biochem Biophys Res Commun; 2007 Feb; 353(2):351-6. PubMed ID: 17178109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface expression of the cystic fibrosis transmembrane conductance regulator mutant DeltaF508 is markedly upregulated by combination treatment with sodium butyrate and low temperature.
    Heda GD; Marino CR
    Biochem Biophys Res Commun; 2000 May; 271(3):659-64. PubMed ID: 10814518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintaining low Ca2+ level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in airway epithelial cells.
    Norez C; Antigny F; Becq F; Vandebrouck C
    Traffic; 2006 May; 7(5):562-73. PubMed ID: 16643279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound.
    Loo TW; Bartlett MC; Clarke DM
    Mol Pharm; 2005; 2(5):407-13. PubMed ID: 16196493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.